Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stabilization of Transaminases in Aqueous-Organic Media by Pyridoxal-5'-phosphate: A Case Study of Transaminase from Desulfomonile tiedjei.

Acta naturae·2026
Same author

Insights into the Functioning of the D-amino Acid Transaminase from Haliscomenobacter Hydrossis via a Structural and Spectral Analysis of its Complex with 3-Aminooxypropionic Acid.

Acta naturae·2024
Same author

Single-point substitution F97M leads to in cellulo crystallization of the biphotochromic protein moxSAASoti.

Biochemical and biophysical research communications·2024
Same author

PDSTP Is the First Drug in Class to Treat Coronavirus Infection.

Herald of the Russian Academy of Sciences·2022
Same author

Highly-Active Recombinant Formate Dehydrogenase from Pathogenic Bacterium Staphylococcus aureus: Preparation and Crystallization.

Biochemistry. Biokhimiia·2020
Same author

Effect of Ketosubstrate on the Product Yield in the Transamination Reaction Catalyzed by Transaminase from Thermoproteus uzoniensis.

Doklady. Biochemistry and biophysics·2020

Related Experiment Video

Updated: Jul 6, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

siRNAs targeting mouse myostatin.

V A Furalyov1, I V Kravchenko, V P Khotchenkov

  • 1Bach Institute of Biochemistry, Russian Academy of Sciences, Leninsky pr. 33, Moscow, Russia.

Biochemistry. Biokhimiia
|April 9, 2008
PubMed
Summary

Researchers developed eight mouse myostatin small interfering RNAs (siRNAs). Five siRNAs effectively reduced myostatin mRNA, with two showing significant 3- and 4-fold decreases for further study.

Area of Science:

  • Molecular Biology
  • Genetics

Background:

  • Myostatin is a key regulator of muscle mass.
  • Understanding myostatin's role requires effective inhibitory tools.

Purpose of the Study:

  • To synthesize and evaluate novel small interfering RNAs (siRNAs) targeting mouse myostatin.
  • To identify potent siRNAs capable of reducing myostatin expression for biological research.

Main Methods:

  • Synthesis of eight distinct mouse myostatin small interfering RNA (siRNA) sequences.
  • In vitro and/or in vivo testing to assess the biological efficacy of synthesized siRNAs.
  • Quantification of myostatin mRNA levels to determine the reduction achieved by each siRNA.

Main Results:

  • Five out of eight synthesized siRNAs demonstrated a significant biological effect.

More Related Videos

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
06:37

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo

Published on: September 18, 2019

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

Related Experiment Videos

Last Updated: Jul 6, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo
06:37

Analyzing Satellite Cell Function During Skeletal Muscle Regeneration by Cardiotoxin Injury and Injection of Self-delivering siRNA In Vivo

Published on: September 18, 2019

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

  • Two specific siRNAs achieved substantial reductions in myostatin mRNA levels, with a 3-fold and a 4-fold decrease, respectively.
  • The efficacy of the developed siRNAs in reducing myostatin mRNA was confirmed.

    • Conclusions:

    • Novel mouse myostatin siRNAs have been successfully synthesized and validated.
    • The identified potent siRNAs provide valuable tools for investigating myostatin's biological functions.
    • These siRNAs are suitable for both in vitro and in vivo applications to study myostatin.